Difficulties in Diagnosing Fabry Disease in Patients with Unexplained Left Ventricular Hypertrophy (LVH): Is the Novel GLA Gene Mutation a Pathogenic Mutation or Polymorphism?
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Desnick RJ, Brady R, Barranger J, Collins AJ, Germain DP, Goldman M, et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med. 2003 Feb 18;138(4):338–46. doi: 10.7326/0003-4819-138-4-200302180-00014.DesnickRJBradyRBarrangerJCollinsAJGermainDPGoldmanMFabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy2003Feb1813843384610.7326/0003-4819-138-4-200302180-00014Open DOISearch in Google Scholar
Pinto LL, Vieira TA, Giugliani R, Schwartz IV. Expression of the disease on female carriers of X-linked lysosomal disorders: a brief review. Orphanet J Rare Dis. 2010 May 28;5:14. doi: 10.1186/1750-1172-5-14.PintoLLVieiraTAGiuglianiRSchwartzIVExpression of the disease on female carriers of X-linked lysosomal disorders: a brief review2010May2851410.1186/1750-1172-5-14Open DOISearch in Google Scholar
Garman SC, Garboczi DN. The molecular defect leading to Fabry disease: structure of human alpha-galactosidase. J Mol Biol. 2004 Mar 19;337(2):319–35. doi: 10.1016/j.jmb.2004.01.035.GarmanSCGarbocziDNThe molecular defect leading to Fabry disease: structure of human alpha-galactosidase2004Mar1933723193510.1016/j.jmb.2004.01.035Open DOISearch in Google Scholar
Kampmann C, Baehner F, Whybra C, Martin C, Wiethoff CM, Ries M, et al. Cardiac manifestations of Anderson-Fabry disease in heterozygous females. J Am Coll Cardiol. 2002 Nov 6;40(9):1668–74. doi: 10.1016/s0735-1097(02)02380-x.KampmannCBaehnerFWhybraCMartinCWiethoffCMRiesMCardiac manifestations of Anderson-Fabry disease in heterozygous females2002Nov640916687410.1016/s0735-1097(02)02380-xOpen DOISearch in Google Scholar
Mehta A, Ricci R, Widmer U, Dehout F, Garcia de Lorenzo A, Kampmann C, et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest. 2004 Mar;34(3):236–42. doi: 10.1111/j.1365-2362.2004.01309.x.MehtaARicciRWidmerUDehoutFGarcia de LorenzoAKampmannCFabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey2004Mar3432364210.1111/j.1365-2362.2004.01309.xOpen DOISearch in Google Scholar
Morrissey RP, Philip KJ, Schwarz ER. Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy. Cardiovasc J Afr. 2011 Jan–Feb;22(1):38–44.MorrisseyRPPhilipKJSchwarzERCardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy2011Jan–Feb2213844Search in Google Scholar
Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA. 1999 Jan 20;281(3):249–54. doi: 10.1001/jama.281.3.249.MeiklePJHopwoodJJClagueAECareyWFPrevalence of lysosomal storage disorders1999Jan2028132495410.1001/jama.281.3.249Open DOISearch in Google Scholar
Barba-Romero MÁ, Rivera-Gallego A, Pintos-Morell G; Spanish FOS-Study Group. Fabry disease in Spain: description of Spanish patients and a comparison with other European countries using data from the Fabry Outcome Survey (FOS). Int J Clin Pract. 2011 Aug;65(8):903–10. doi: 10.1111/j.1742-1241.2011.02695.x.Barba-RomeroMÁRivera-GallegoAPintos-MorellGSpanish FOS-Study GroupFabry disease in Spain: description of Spanish patients and a comparison with other European countries using data from the Fabry Outcome Survey (FOS)2011Aug6589031010.1111/j.1742-1241.2011.02695.xOpen DOISearch in Google Scholar
Linthorst GE, Bouwman MG, Wijburg FA, Aerts JM, Poorthuis BJ, Hollak CE. Screening for Fabry disease in high-risk populations: a systematic review. J Med Genet. 2010 Apr;47(4):217–22. doi: 10.1136/jmg.2009.072116.LinthorstGEBouwmanMGWijburgFAAertsJMPoorthuisBJHollakCEScreening for Fabry disease in high-risk populations: a systematic review2010Apr4742172210.1136/jmg.2009.072116Open DOISearch in Google Scholar
Mehta A, Clarke JT, Giugliani R, Elliott P, Linhart A, Beck M, et al; FOS Investigators. Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey. J Med Genet. 2009 Aug;46(8):548–52. doi: 10.1136/jmg.2008.065904.MehtaAClarkeJTGiuglianiRElliottPLinhartABeckMFOS InvestigatorsNatural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey2009Aug4685485210.1136/jmg.2008.065904Open DOISearch in Google Scholar
Waldek S, Patel MR, Banikazemi M, Lemay R, Lee P. Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry. Genet Med. 2009 Nov;11(11):790–6. doi: 10.1097/GIM.0b013e3181bb05bb.WaldekSPatelMRBanikazemiMLemayRLeePLife expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry2009Nov1111790610.1097/GIM.0b013e3181bb05bbOpen DOISearch in Google Scholar
Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, Yoshida A, Kuriyama M, Hayashibe H, Sakuraba H, et al. An atypical variant of Fabry’s disease in men with left ventricular hypertrophy. N Engl J Med. 1995 Aug 3;333(5):288–93. doi: 10.1056/NEJM199508033330504.NakaoSTakenakaTMaedaMKodamaCTanakaATaharaMYoshidaAKuriyamaMHayashibeHSakurabaHAn atypical variant of Fabry’s disease in men with left ventricular hypertrophy1995Aug333352889310.1056/NEJM199508033330504Open DOISearch in Google Scholar
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233–70. doi: 10.1093/ehjci/jev014.LangRMBadanoLPMor-AviVAfilaloJArmstrongAErnandeLRecommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging2015Mar1632337010.1093/ehjci/jev014Open DOISearch in Google Scholar
Niemann M, Rolfs A, Störk S, Bijnens B, Breunig F, Beer M, et al. Gene mutations versus clinically relevant phenotypes: lyso-Gb3 defines Fabry disease. Circ Cardiovasc Genet. 2014 Feb;7(1):8–16. doi: 10.1161/CIRCGENETICS.113.000249.NiemannMRolfsAStörkSBijnensBBreunigFBeerMGene mutations versus clinically relevant phenotypes: lyso-Gb3 defines Fabry disease2014Feb7181610.1161/CIRCGENETICS.113.000249Open DOISearch in Google Scholar
Niemann M, Rolfs A, Giese A, Mascher H, Breunig F, Ertl G, Wanner C, Weidemann F. Lyso-Gb3 Indicates that the Alpha-Galactosidase A Mutation D313Y is not Clinically Relevant for Fabry Disease. JIMD Rep. 2013;7:99–102. doi: 10.1007/8904_2012_154.NiemannMRolfsAGieseAMascherHBreunigFErtlGWannerCWeidemannFLyso-Gb3 Indicates that the Alpha-Galactosidase A Mutation D313Y is not Clinically Relevant for Fabry Disease201379910210.1007/8904_2012_154Open DOISearch in Google Scholar
Germain DP. Fabry disease. Orphanet J Rare Dis. 2010 Nov 22;5:30. doi: 10.1186/1750-1172-5-30GermainDPFabry disease2010Nov2253010.1186/1750-1172-5-30Open DOISearch in Google Scholar
Chimenti C, Pieroni M, Morgante E, Antuzzi D, Russo A, Russo MA, et al. Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy. Circulation. 2004 Aug 31;110(9):1047–53. doi: 10.1161/01.CIR.0000139847.74101.03.ChimentiCPieroniMMorganteEAntuzziDRussoARussoMAPrevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy2004Aug31110910475310.1161/01.CIR.0000139847.74101.03Open DOISearch in Google Scholar
Havndrup O, Christiansen M, Stoevring B, Jensen M, Hoffman-Bang J, Andersen PS, et al. Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women. Eur J Heart Fail. 2010 Jun;12(6):535–40. doi: 10.1093/eurjhf/hfq073.HavndrupOChristiansenMStoevringBJensenMHoffman-BangJAndersenPSFabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women2010Jun1265354010.1093/eurjhf/hfq073Open DOISearch in Google Scholar
Sachdev B, Takenaka T, Teraguchi H, Tei C, Lee P, McKenna WJ, et al. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation. 2002 Mar 26;105(12):1407–11. doi: 10.1161/01.cir.0000012626.81324.38.SachdevBTakenakaTTeraguchiHTeiCLeePMcKennaWJPrevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy2002Mar261051214071110.1161/01.cir.0000012626.81324.38Open DOISearch in Google Scholar
Ommen SR, Nishimura RA, Edwards WD. Fabry disease: a mimic for obstructive hypertrophic cardiomyopathy? Heart. 2003 Aug;89(8):929–30. doi: 10.1136/heart.89.8.929.OmmenSRNishimuraRAEdwardsWDFabry disease: a mimic for obstructive hypertrophic cardiomyopathy?2003Aug8989293010.1136/heart.89.8.929Open DOISearch in Google Scholar
Monserrat L, Gimeno-Blanes JR, Marín F, Hermida-Prieto M, García-Honrubia A, Pérez I, et al. Prevalence of fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2007 Dec 18;50(25):2399–403. doi: 10.1016/j.jacc.2007.06.062.MonserratLGimeno-BlanesJRMarínFHermida-PrietoMGarcía-HonrubiaAPérezIPrevalence of fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy2007Dec185025239940310.1016/j.jacc.2007.06.062Open DOISearch in Google Scholar
Elliott P, Baker R, Pasquale F, Quarta G, Ebrahim H, Mehta AB, et al; ACES study group. Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease survey. Heart. 2011 Dec;97(23):1957–60. doi: 10.1136/heartjnl-2011-300364.ElliottPBakerRPasqualeFQuartaGEbrahimHMehtaABACES study groupPrevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease survey2011Dec972319576010.1136/heartjnl-2011-300364Open DOISearch in Google Scholar
Hagège AA, Caudron E, Damy T, Roudaut R, Millaire A, Etchecopar-Chevreuil C, et al; FOCUS study investigators. Screening patients with hypertrophic cardiomyopathy for Fabry disease using a filter-paper test: the FOCUS study. Heart. 2011 Jan;97(2):131–6. doi: 10.1136/hrt.2010.200188.HagègeAACaudronEDamyTRoudautRMillaireAEtchecopar-ChevreuilCFOCUS study investigatorsScreening patients with hypertrophic cardiomyopathy for Fabry disease using a filter-paper test: the FOCUS study2011Jan972131610.1136/hrt.2010.200188Open DOISearch in Google Scholar
Mawatari K, Yasukawa H, Oba T, Nagata T, Togawa T, Tsukimura T, et al. Screening for Fabry disease in patients with left ventricular hypertrophy. Int J Cardiol. 2013 Aug 10;167(3):1059–61. doi: 10.1016/j.ijcard.2012.10.076.MawatariKYasukawaHObaTNagataTTogawaTTsukimuraTScreening for Fabry disease in patients with left ventricular hypertrophy2013Aug10167310596110.1016/j.ijcard.2012.10.076Open DOISearch in Google Scholar
Terryn W, Deschoenmakere G, De Keyser J, Meersseman W, Van Biesen W, Wuyts B, et al. Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy. Int J Cardiol. 2013 Sep 10;167(6):2555–60. doi: 10.1016/j.ijcard.2012.06.069.TerrynWDeschoenmakereGDe KeyserJMeerssemanWVan BiesenWWuytsBPrevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy2013Sep10167625556010.1016/j.ijcard.2012.06.069Open DOISearch in Google Scholar
Palecek T, Honzikova J, Poupetova H, Vlaskova H, Kuchynka P, Golan L, et al. Prevalence of Fabry disease in male patients with unexplained left ventricular hypertrophy in primary cardiology practice: prospective Fabry cardiomyopathy screening study (FACSS). J Inherit Metab Dis. 2014 May;37(3):455–60. doi: 10.1007/s10545-013-9659-2.PalecekTHonzikovaJPoupetovaHVlaskovaHKuchynkaPGolanLPrevalence of Fabry disease in male patients with unexplained left ventricular hypertrophy in primary cardiology practice: prospective Fabry cardiomyopathy screening study (FACSS)2014May3734556010.1007/s10545-013-9659-2Open DOISearch in Google Scholar
Baptista A, Magalhães P, Leão S, Carvalho S, Mateus P, Moreira I. Screening for Fabry disease in left ventricular hypertrophy: documentation of a novel mutation. Arq Bras Cardiol. 2015 Aug;105(2):139–44. doi: 10.5935/abc.20150090.BaptistaAMagalhãesPLeãoSCarvalhoSMateusPMoreiraIScreening for Fabry disease in left ventricular hypertrophy: documentation of a novel mutation2015Aug10521394410.5935/abc.20150090Open DOISearch in Google Scholar
Vieitez I, Souto-Rodriguez O, Fernandez-Mosquera L, San Millan B, Teijeira S, Fernandez-Martin J, et al. Fabry disease in the Spanish population: observational study with detection of 77 patients. Orphanet J Rare Dis. 2018 Apr 10;13(1):52. doi: 10.1186/s13023-018-0792-8.VieitezISouto-RodriguezOFernandez-MosqueraLSan MillanBTeijeiraSFernandez-MartinJFabry disease in the Spanish population: observational study with detection of 77 patients2018Apr101315210.1186/s13023-018-0792-8Open DOISearch in Google Scholar
Maron MS, Xin W, Sims KB, Butler R, Haas TS, Rowin EJ, et al. Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy. Am J Med. 2018 Feb;131(2):200.e1–200.e8. doi: 10.1016/j.amjmed.2017.09.010.MaronMSXinWSimsKBButlerRHaasTSRowinEJIdentification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy2018Feb1312200.e1200.e810.1016/j.amjmed.2017.09.010Open DOISearch in Google Scholar
Kim WS, Kim HS, Shin J, Park JC, Yoo HW, Takenaka T, et al. Prevalence of Fabry Disease in Korean Men with Left Ventricular Hypertrophy. J Korean Med Sci. 2019 Feb 15;34(7):e63. doi: 10.3346/jkms.2019.34.e63.KimWSKimHSShinJParkJCYooHWTakenakaTPrevalence of Fabry Disease in Korean Men with Left Ventricular Hypertrophy2019Feb15347e6310.3346/jkms.2019.34.e63Open DOISearch in Google Scholar
Oder D, Üçeyler N, Liu D, Hu K, Petritsch B, Sommer C, et al. Organ manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y. BMJ Open. 2016 Apr 8;6(4):e010422. doi: 10.1136/bmjopen-2015-010422.OderDÜçeylerNLiuDHuKPetritschBSommerCOrgan manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y2016Apr864e01042210.1136/bmjopen-2015-010422Open DOISearch in Google Scholar
Branton MH, Schiffmann R, Sabnis SG, Murray GJ, Quirk JM, Altarescu G, et al. Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine (Baltimore). 2002 Mar;81(2):122–38. doi: 10.1097/00005792-200203000-00003.BrantonMHSchiffmannRSabnisSGMurrayGJQuirkJMAltarescuGNatural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course2002Mar8121223810.1097/00005792-200203000-00003Open DOISearch in Google Scholar
Ferreira S, Ortiz A, Germain DP, Viana-Baptista M, Caldeira-Gomes A, Camprecios M, et al. The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies. Mol Genet Metab. 2015 Feb;114(2):248–58. doi: 10.1016/j.ymgme.2014.11.004.FerreiraSOrtizAGermainDPViana-BaptistaMCaldeira-GomesACampreciosMThe alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies2015Feb11422485810.1016/j.ymgme.2014.11.004Open DOISearch in Google Scholar
Eng CM, Desnick RJ. Molecular basis of Fabry disease: mutations and polymorphisms in the human alpha-galactosidase A gene. Hum Mutat. 1994;3(2):103–11. doi: 10.1002/humu.1380030204.EngCMDesnickRJMolecular basis of Fabry disease: mutations and polymorphisms in the human alpha-galactosidase A gene1994321031110.1002/humu.1380030204Open DOISearch in Google Scholar
Eng CM, Ashley GA, Burgert TS, Enriquez AL, D’Souza M, Desnick RJ. Fabry disease: thirty-five mutations in the alpha-galactosidase A gene in patients with classic and variant phenotypes. Mol Med. 1997 Mar;3(3):174–82.EngCMAshleyGABurgertTSEnriquezALD’SouzaMDesnickRJFabry disease: thirty-five mutations in the alpha-galactosidase A gene in patients with classic and variant phenotypes1997Mar3317482Search in Google Scholar
Van der Tol L, Smid BE, Poorthuis BJ, Biegstraaten M, Deprez RH, Linthorst GE, et al. A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance. J Med Genet. 2014 Jan;51(1):1–9. doi: 10.1136/jmedgenet-2013-101857.Van der TolLSmidBEPoorthuisBJBiegstraatenMDeprezRHLinthorstGEA systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance2014Jan5111910.1136/jmedgenet-2013-101857Open DOISearch in Google Scholar
Hoffmann B, Beck M, Sunder-Plassmann G, Borsini W, Ricci R, Mehta A; FOS European Investigators. Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy--a retrospective analysis from the Fabry Outcome Survey. Clin J Pain. 2007 Jul–Aug;23(6):535–42. doi: 10.1097/AJP.0b013e318074c986.HoffmannBBeckMSunder-PlassmannGBorsiniWRicciRMehtaAFOS European InvestigatorsNature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy--a retrospective analysis from the Fabry Outcome Survey2007Jul–Aug2365354210.1097/AJP.0b013e318074c986Open DOISearch in Google Scholar